UBS O'Connor’s Endo International plc ENDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-64,474
Closed -$370K – 1085
2021
Q1
$478K Buy
64,474
+4,465
+7% +$36.2K 0.01% 609
2020
Q4
$431K Sell
60,009
-500,000
-89% -$2.61M 0.01% 502
2020
Q3
$1.85M Buy
560,009
+500,000
+833% +$1.6M 0.05% 187
2020
Q2
$206K Sell
60,009
-150,000
-71% -$575K ﹤0.01% 344
2020
Q1
$777K Sell
210,009
-210,000
-50% -$1.06M 0.02% 238
2019
Q4
$1.97M Sell
420,009
-70,000
-14% -$312K 0.06% 194
2019
Q3
$1.57M Buy
490,009
+370,009
+308% +$1.19M 0.04% 183
2019
Q2
$494K Buy
+120,000
New +$757K 0.01% 198

Other funds holding ENDP

UBS O'Connor's ENDP Position: Q2 2021 in Review

UBS O'Connor sold out of Endo International plc (ENDP) in Q2 2021, closing a stake of 64,474 shares — an estimated $370K sold.

UBS O'Connor first reported a position in ENDP in Q2 2019 and held it in 8 quarters. The position peaked at $1.97M in Q4 2019. 203 funds tracked by Wall St. Rank hold ENDP as of Q2 2021.

  • UBS O'Connor reported no remaining Endo International plc position as of Q2 2021 after selling out during the quarter.
  • UBS O'Connor sold 64,474 Endo International plc shares in Q2 2021, an estimated $370K.
  • UBS O'Connor first reported a position in Endo International plc in Q2 2019 and held it in 8 quarters.
  • UBS O'Connor's Endo International plc position peaked at $1.97M in Q4 2019.
  • 203 funds tracked by Wall St. Rank held Endo International plc as of Q2 2021.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.